farnesol has been researched along with Experimental Mammary Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Huang, Y; Li, J; Li, S; Venkataramanan, R; Zhang, P; Zhang, X; Zhao, W | 1 |
| Huang, Y; Li, J; Li, S; Liu, K; Ma, X; Xu, J; Zhang, X | 1 |
| Lynch, AR; McPherson, RA; Neal, LR; Santen, RJ; Yue, W | 1 |
3 other study(ies) available for farnesol and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel.
Topics: Animals; Breast Neoplasms; Disease Models, Animal; Drug Carriers; Farnesol; Female; HCT116 Cells; Hemolysis; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Micelles; Paclitaxel; Polyethylene Glycols; Salicylates | 2014 |
Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Farnesol; Female; Humans; Hydrophobic and Hydrophilic Interactions; Mammary Neoplasms, Experimental; Mice; Micelles; Nanostructures; Oxidation-Reduction; Paclitaxel; Polyethylene Glycols; Salicylates | 2014 |
Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclodextrins; Dose-Response Relationship, Drug; Estradiol; Farnesol; Female; Humans; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; ras Proteins; Salicylates; Xenograft Model Antitumor Assays | 2006 |